Serum S100B and LDH at baseline and during therapy predict the outcome of metastatic melanoma patients treated with BRAF inhibitors

DSpace Repository

Serum S100B and LDH at baseline and during therapy predict the outcome of metastatic melanoma patients treated with BRAF inhibitors

Author: Gassenmaier, Maximilian; Lenders, Max M.; Forschner, Andrea; Leiter, Ulrike; Weide, Benjamin; Garbe, Claus; Eigentler, Thomas K.; Wagner, Nikolaus B.
Tübinger Autor(en):
Gassenmaier, Maximilian
Lenders, Max Matthias
Forschner, Andrea Lydia
Leiter-Stöppke, Ulrike
Weide, Benjamin Matthias
Garbe, Claus
Eigentler, Thomas
Wagner, Nikolaus B.
Published in: Targeted Oncology (2021), Bd. 16, H. 2, S. 197-205
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s11523-021-00792-8
ISSN: 1776-260X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)